145 related articles for article (PubMed ID: 16437193)
1. Body composition and vertebral fracture risk in female patients treated with glucocorticoid.
Kaji H; Tobimatsu T; Naito J; Iu MF; Yamauchi M; Sugimoto T; Chihara K
Osteoporos Int; 2006; 17(4):627-33. PubMed ID: 16437193
[TBL] [Abstract][Full Text] [Related]
2. The threshold of bone mineral density for vertebral fracture in female patients with glucocorticoid-induced osteoporosis.
Kaji H; Yamauchi M; Chihara K; Sugimoto T
Endocr J; 2006 Feb; 53(1):27-34. PubMed ID: 16543669
[TBL] [Abstract][Full Text] [Related]
3. Bone density threshold and other predictors of vertebral fracture in patients receiving oral glucocorticoid therapy.
Van Staa TP; Laan RF; Barton IP; Cohen S; Reid DM; Cooper C
Arthritis Rheum; 2003 Nov; 48(11):3224-9. PubMed ID: 14613287
[TBL] [Abstract][Full Text] [Related]
4. Determinants of bone mineral density and spinal fracture risk in postmenopausal Japanese women.
Nakaoka D; Sugimoto T; Kaji H; Kanzawa M; Yano S; Yamauchi M; Sugishita T; Chihara K
Osteoporos Int; 2001; 12(7):548-54. PubMed ID: 11527051
[TBL] [Abstract][Full Text] [Related]
5. The relationship between body composition and fracture risk using the FRAX model in central south Chinese postmenopausal women.
Zhang Z; Shen X; Zhang H; Li S; Zhou H; Wu X; Sheng Z; Liao E
Clin Endocrinol (Oxf); 2012 Oct; 77(4):524-30. PubMed ID: 22469329
[TBL] [Abstract][Full Text] [Related]
6. Postmenopausal Canarian women receiving oral glucocorticoids have an increased prevalence of vertebral fractures and low values of bone mineral density measured by quantitative computer tomography and dual X-ray absorptiometry, without significant changes in parathyroid hormone.
Sosa M; Jódar E; Saavedra P; Navarro MC; Gómez de Tejada MJ; Martín A; Peña P; Gómez J
Eur J Intern Med; 2008 Jan; 19(1):51-6. PubMed ID: 18206602
[TBL] [Abstract][Full Text] [Related]
7. Fracture risk in oral glucocorticoid users: a Bayesian meta-regression leveraging control arms of osteoporosis clinical trials.
Amiche MA; Albaum JM; Tadrous M; Pechlivanoglou P; Lévesque LE; Adachi JD; Cadarette SM
Osteoporos Int; 2016 May; 27(5):1709-18. PubMed ID: 26694595
[TBL] [Abstract][Full Text] [Related]
8. Quantitative computed tomography of the lumbar spine, not dual x-ray absorptiometry, is an independent predictor of prevalent vertebral fractures in postmenopausal women with osteopenia receiving long-term glucocorticoid and hormone-replacement therapy.
Rehman Q; Lang T; Modin G; Lane NE
Arthritis Rheum; 2002 May; 46(5):1292-7. PubMed ID: 12115236
[TBL] [Abstract][Full Text] [Related]
9. Vertebral fracture and bone mineral density in women receiving high dose glucocorticoids for treatment of autoimmune diseases.
Kumagai S; Kawano S; Atsumi T; Inokuma S; Okada Y; Kanai Y; Kaburaki J; Kameda H; Suwa A; Hagiyama H; Hirohata S; Makino H; Hashimoto H
J Rheumatol; 2005 May; 32(5):863-9. PubMed ID: 15868623
[TBL] [Abstract][Full Text] [Related]
10. Low bone mineral density, but not epidural steroid injection, is associated with fracture in postmenopausal women with low back pain.
Yi Y; Hwang B; Son H; Cheong I
Pain Physician; 2012; 15(6):441-9. PubMed ID: 23159959
[TBL] [Abstract][Full Text] [Related]
11. High prevalence of asymptomatic vertebral fractures in post-menopausal women receiving chronic glucocorticoid therapy: a cross-sectional outpatient study.
Angeli A; Guglielmi G; Dovio A; Capelli G; de Feo D; Giannini S; Giorgino R; Moro L; Giustina A
Bone; 2006 Aug; 39(2):253-9. PubMed ID: 16574519
[TBL] [Abstract][Full Text] [Related]
12. Association of Visceral and Subcutaneous Fat Mass With Bone Density and Vertebral Fractures in Women With Severe Obesity.
Crivelli M; Chain A; da Silva ITF; Waked AM; Bezerra FF
J Clin Densitom; 2021; 24(3):397-405. PubMed ID: 33109469
[TBL] [Abstract][Full Text] [Related]
13. Serum levels of insulin-like growth factor (IGF); IGF-binding proteins-3, -4, and -5; and their relationships to bone mineral density and the risk of vertebral fractures in postmenopausal women.
Yamaguchi T; Kanatani M; Yamauchi M; Kaji H; Sugishita T; Baylink DJ; Mohan S; Chihara K; Sugimoto T
Calcif Tissue Int; 2006 Jan; 78(1):18-24. PubMed ID: 16397738
[TBL] [Abstract][Full Text] [Related]
14. Differences in hip quantitative computed tomography (QCT) measurements of bone mineral density and bone strength between glucocorticoid-treated and glucocorticoid-naive postmenopausal women.
Lian KC; Lang TF; Keyak JH; Modin GW; Rehman Q; Do L; Lane NE
Osteoporos Int; 2005 Jun; 16(6):642-50. PubMed ID: 15455195
[TBL] [Abstract][Full Text] [Related]
15. Calcaneus ultrasonometry and dual-energy X-ray absorptiometry for the evaluation of vertebral fracture risk.
Frediani B; Acciai C; Falsetti P; Baldi F; Filippou G; Siagkri C; Spreafico A; Galeazzi M; Marcolongo R
Calcif Tissue Int; 2006 Oct; 79(4):223-9. PubMed ID: 16969597
[TBL] [Abstract][Full Text] [Related]
16. Association of Fat Body Mass With Vertebral Fractures in Postmenopausal Women With Early Breast Cancer Undergoing Adjuvant Aromatase Inhibitor Therapy.
Pedersini R; Amoroso V; Maffezzoni F; Gallo F; Turla A; Monteverdi S; Ardine M; Ravanelli M; Vassalli L; Rodella F; Formenti AM; Dalla Volta A; Simoncini EL; Giustina A; Maroldi R; Berruti A
JAMA Netw Open; 2019 Sep; 2(9):e1911080. PubMed ID: 31560383
[TBL] [Abstract][Full Text] [Related]
17. Relation of body fat distribution to femoral neck bone density and endometrial thickness in postmenopausal women.
Oktem O; Kucuk M; Ozer K; Sezen D; Durmusoglu F
Gynecol Endocrinol; 2010 Jun; 26(6):440-4. PubMed ID: 20175708
[TBL] [Abstract][Full Text] [Related]
18. High-dose glucocorticoid treatment induces rapid loss of trabecular bone mineral density and lean body mass.
Natsui K; Tanaka K; Suda M; Yasoda A; Sakuma Y; Ozasa A; Ozaki S; Nakao K
Osteoporos Int; 2006 Jan; 17(1):105-8. PubMed ID: 15886861
[TBL] [Abstract][Full Text] [Related]
19. Relationship between pretreatment bone resorption and vertebral fracture incidence in postmenopausal osteoporotic women treated with risedronate.
Seibel MJ; Naganathan V; Barton I; Grauer A
J Bone Miner Res; 2004 Feb; 19(2):323-9. PubMed ID: 14969403
[TBL] [Abstract][Full Text] [Related]
20. Urinary deoxypyridinoline is a BMD-independent marker for prevalent vertebral fractures in postmenopausal women treated with glucocorticoid.
Kaji H; Yamauchi M; Yamaguchi T; Sugimoto T
Osteoporos Int; 2010 Sep; 21(9):1585-90. PubMed ID: 19924495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
